Video Briefs - 510(k) vs. PMA Regulatory Strategy - Approaching FDA
Paul Yock interviews Howard Holstein, regulatory attorney, on 510(k) vs. PMA Regulatory Strategies: Question 5: "How would a company approach the FDA for products that span multiple clinical areas?"